View Author
patient stent group study pre-se personality revascularization disease ses group implantation month event ses implantation death outcome target vessel revascularization pre-ses group treatment rotterdam cardiology hospital vessel infarction intervention sirolimus-eluting sirolimus-eluting stents restenosi lesion hospital artery target stenting percutaneou surgery cardiology period trial three-vessel disease registry follow-up table drug-eluting incidence procedure result ds 14 bifurcation stenting randomized rotterdam circulation rapamycin-eluting stent ͻ0.01 figure research bifurcation risk factors factor sirolimus-eluting stent implantation reduction practice 1 year angiographic signi characteristic population prognosis three-vessel drug-eluting stent era percentage introduction world ” interventional target lesion revascularization impact effect heart diabetes shift world mace percentages pci group ses period
